FDA Compliance

FDA Warning Letter – Major CGMP deficiencies

by

FDA Warning Letter An FDA warning letter is a serious regulatory communication that identifies significant violations of FDA requirements and allows a pharmaceutical manufacturer to take corrective action. In this case, the FDA warning letter identifies three major CGMP deficiencies related to finished-product testing, incoming material controls, and cleaning validation. These findings demonstrate the importance … Read more

Pharmaceutical Quality Risk Management: FDA & ICH Q9 Guide

by

Quality Risk Management for New Products, Processes, Equipment, Facilities, Technology Transfer and Scale-Up   Introducing a new pharmaceutical product, manufacturing process, equipment, facility modification, technology transfer, scale-up activity, or process change can create significant quality risks. A change that appears technically simple may affect: Critical Quality Attributes (CQAs) Critical Process Parameters (CPPs) Material attributes Process capability … Read more